ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
129.036,10
-0,07%
S&P 500
5.987,37
0,30%
US Dollar vs BRL
5,7992
-0,02%
Bitcoin
94.642,40
1,67%
Brent Oil
72,575
-0,04%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Bio Path Holdings Inc (BPTH)

  7. Bio Path Holdings Inc (BPTH) Notícias

BPTH

Bio Path (BPTH)

Bio Path Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BPTH
DataHoraFonteTítuloCódigoCompanhia
25/11/202418:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
15/11/202409:00GlobeNewswire Inc.Bio-Path Holdings Reports Third Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
13/11/202413:15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BPTHBio Path Holdings Inc
08/11/202409:00GlobeNewswire Inc.Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024NASDAQ:BPTHBio Path Holdings Inc
28/10/202417:37Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BPTHBio Path Holdings Inc
28/10/202417:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BPTHBio Path Holdings Inc
28/10/202417:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BPTHBio Path Holdings Inc
23/10/202408:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BPTHBio Path Holdings Inc
23/10/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BPTHBio Path Holdings Inc
22/10/202416:11Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BPTHBio Path Holdings Inc
18/10/202418:12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BPTHBio Path Holdings Inc
17/10/202417:37Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
10/10/202418:24GlobeNewswire Inc.Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
08/10/202421:00GlobeNewswire Inc.Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
08/10/202408:00GlobeNewswire Inc.Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of ObesityNASDAQ:BPTHBio Path Holdings Inc
16/09/202408:00GlobeNewswire Inc.Bio-Path Holdings Announces Publication in BiomedicinesNASDAQ:BPTHBio Path Holdings Inc
03/09/202408:00GlobeNewswire Inc.Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:BPTHBio Path Holdings Inc
21/08/202408:00GlobeNewswire Inc.Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid TumorsNASDAQ:BPTHBio Path Holdings Inc
15/08/202408:00GlobeNewswire Inc.Bio-Path Holdings Reports Second Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
14/08/202417:41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPTHBio Path Holdings Inc
08/08/202408:00GlobeNewswire Inc.Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024NASDAQ:BPTHBio Path Holdings Inc
01/08/202419:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPTHBio Path Holdings Inc
08/07/202408:00GlobeNewswire Inc.Bio-Path Holdings Provides Clinical Update and Expansion PlansNASDAQ:BPTHBio Path Holdings Inc
14/06/202408:00GlobeNewswire Inc.Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association CongressNASDAQ:BPTHBio Path Holdings Inc
03/06/202408:00GlobeNewswire Inc.Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
24/05/202408:00GlobeNewswire Inc.Bio-Path Holdings to Present Data at 2024 European Hematology Association CongressNASDAQ:BPTHBio Path Holdings Inc
23/05/202418:00GlobeNewswire Inc.Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
15/05/202408:50IH Market NewsU.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices DropNASDAQ:BPTHBio Path Holdings Inc
15/05/202408:00GlobeNewswire Inc.Bio-Path Holdings Reports First Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
08/05/202408:00GlobeNewswire Inc.Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024NASDAQ:BPTHBio Path Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BPTH

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 60%* para TRADER BRASIL

1 ano 40%, 2 anos 50% e *3 anos 60%

*Ao longo de 3 anos $ 881.64 apenas $ 352.65